Becton Dickinson & Co
BDX- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0000010795
In the last 90 days, Becton Dickinson & Co insiders filed 0 open-market purchases and 4 sales; 1,446 institutions reported holding it in 13F filings for Q2 2026, worth $41.2B in total; superinvestors Greenhaven Associates and Harris Associates (Oakmark) hold it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Becton Dickinson & Co insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 4 filings
- 3 insiders, $1.25M in total
- Insiders trading
- 3
- Net value
- −$1.25M
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Becton Dickinson & Co, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Roque Vitor | EVP & Chief Financial Officer | 8,041 | Sep 3, 2026 | 3 |
| Feld Michael | EVP, Chief Revenue Officer | 19,720 | Aug 27, 2026 | 13 |
| Polen Thomas E Jr | Chairman, CEO and President | 110,163 | Aug 14, 2026 | 3 |
| Goette Roland | EVP and President, EMEA | 14,856 | Aug 12, 2026 | 2 |
| Huffines Robert Luther | Director | 1,279 | Aug 6, 2026 | 5 |
| Byington Carrie L | Director | 5,018 | Aug 6, 2026 | 5 |
| Muhsin Bilal | EVP & President Connected Care | 41,359 | Jul 6, 2026 | 2 |
| Garrison Michael David | EVP & Pres Med.Essntl&BioPharm | 13,172 | Jun 25, 2026 | 5 |
| Menziuso Peter | EVP and President, BDI | 14,258 | Jun 2, 2026 | 1 |
| Neal Shana Carol | EVP and Chief People Officer | 23,966 | Apr 6, 2026 | 2 |
| Minnix Lanesha | EVP and General Counsel | 7,492 | Mar 17, 2026 | 1 |
| Spikner Pamela L. | SVP Controller & CAO | 3,323 | Mar 4, 2026 | 3 |
| Scott Bertram L | Director | 36,763 | Feb 18, 2026 | 3 |
| Jones Christopher Ian Montague | Director | 24,304 | Feb 5, 2026 | 3 |
| Ring Timothy M | Director | 59,160 | Jan 29, 2026 | 1 |
| Eckert R Andrew | Director | 10,423 | Jan 29, 2026 | 1 |
| Hayes Gregory | Director | 7,159 | Jan 29, 2026 | 1 |
| Henderson Jeffrey William | Director | 9,143 | Jan 29, 2026 | 1 |
| Brown William M | Director | 4,663 | Jan 29, 2026 | 1 |
| Wright Jacqueline | Director | 1,279 | Jan 29, 2026 | 2 |
| Waldstreicher Joanne | Director | 3,391 | Jan 29, 2026 | 1 |
| Shan David | EVP and Chief ISC Officer | 8,926 | Jan 6, 2026 | 2 |
| DelOrefice Christopher | EVP & Chief Financial Officer | 22,982 | Dec 1, 2025 | 1 |
| Mocherla Pavan Kumar | EVP & President, Greater Asia | 5,763 | Dec 1, 2025 | 1 |
| Byrd Richard | EVP & President Interventional | 13,849 | Dec 1, 2025 | 1 |
| Fraser Claire | Director | 22,226 | Sep 11, 2025 | 0 |
| Burzik Catherine M | Director | 14,264 | Jan 30, 2025 | 0 |
| Quinn Michelle | EVP and General Counsel | 6,927 | Dec 3, 2024 | 0 |
| Ezell Antoine C | EVP, President Americas & CMO | 11,970 | Nov 29, 2024 | 0 |
| Spoerel Thomas J | SVPController & Chief Acct Off | 1,928 | Jul 2, 2024 | 0 |
| Hickey David | EVP & President, Life Sciences | 5,862 | Nov 28, 2023 | 0 |
| Larsen Marshall O | Director | 28,919 | Jan 26, 2023 | 0 |
| Khichi Samrat S. | EVP and General Counsel | 9,251 | Jan 5, 2023 | 0 |
| Grover Rishi | EVP and Chief ISC Officer | 9,439 | Jul 12, 2022 | 0 |
| Lim James C | Executive Vice President | 23,941 | Jun 24, 2022 | 0 |
| Larson Betty D | EVP HR & CHRO | 5,872 | Feb 28, 2022 | 0 |
| Campion Simon D | EVP and Segment President | 10,319 | Feb 14, 2022 | 0 |
| Conroy Alexandre | EVP of Integrated Supply Chain | 21,260 | Feb 7, 2022 | 0 |
| Melcher David F | Director | 6,180 | Jan 27, 2022 | 0 |
| Pomeroy Claire | Director | 9,982 | Jan 26, 2022 | 0 |
| Reidy Christopher R | CFO and EVP of Administration | 31,524 | Nov 30, 2021 | 0 |
| Mas Ribo Alberto | EVP and Pres, Life Sciences | 11,662 | Nov 30, 2021 | 0 |
| Rimel Rebecca W | Director | 10,618 | Sep 8, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 9, 2023 (view filing) | Aug 8 | 1 day | Garrison Michael DavidEVP & President Medical | SSale | −1.30K | $277.13 | −$360.3K | −20.1%5.16K after | 10b5-1 |
| Feb 6, 2023 (view filing) | Feb 3 | 3 days | Byrd RichardEVP & President Interventional | SSale | −1.42K | $248.60 | −$353.3K | −25.6%4.12K after | |
| Aug 17, 2022 (view filing) | Aug 15 | 2 days | Hickey DavidEVP & President, Life Sciences | SSale | −475 | $265.00 | −$125.9K | −12.5%3.33K after | |
| Aug 17, 2022 (view filing) | Aug 15 | 2 days | Polen Thomas E JrChairman, CEO and President | SSale | −9.50K | $265.13 | −$2.52M | −24.8%28.9K after | |
| Aug 11, 2022 (view filing) | Aug 8-9 | 3 daysLate | Khichi Samrat S.EVP and General Counsel | SSale | −16.5K | $260.44 | −$4.29M | −73.5%5.93K after | 2 lots |
| Aug 11, 2022 (view filing) | Aug 9 | 2 days | Polen Thomas E JrExecutive Vice President | SSale | −1.65K | $260.00 | −$429.5K | −5.4%28.9K after | |
| Jun 9, 2022 (view filing) | Jun 7 | 2 days | Spoerel Thomas JVP Controller & Chief Acct Off | SSale | −443 | $260.00 | −$115.2K | −29.5%1.06K after | |
| May 10, 2022 (view filing) | May 6 | 4 days | Hickey DavidEVP & President, Life Sciences | SSale | −475 | $256.00 | −$121.6K | −11.1%3.81K after | |
| Feb 28, 2022 (view filing) | Feb 25 | 3 days | Larson Betty DEVP HR & CHRO | SSale | −14.4K | $271.90 | −$3.91M | −71.0%5.87K after | 8 lots |
| Feb 10, 2022 (view filing) | Feb 8 | 2 days | Fraser ClaireDirector | SSale | −841 | $271.70 | −$228.5K | −3.8%21.6K after | |
| Feb 7, 2022 (view filing) | Feb 3 | 4 days | Conroy AlexandreEVP of Integrated Supply Chain | SSale | −6.41K | $270.16 | −$1.73M | −23.2%21.3K after | |
| Dec 17, 2021 (view filing) | Dec 16 | 1 day | Larson Betty DEVP HR & CHRO | SSale | −3.34K | $255.00 | −$852.0K | −36.3%5.87K after | 2 lots |
| Dec 9, 2021 (view filing) | Dec 7 | 2 days | Spoerel Thomas JVP Controller & Chief Acct Off | SSale | −233 | $250.00 | −$58.3K | −17.8%1.08K after | |
| Sep 8, 2021 (view filing) | Sep 8 | Same day | Spoerel Thomas JVP Controller & Chief Acct Off | SSale | −267 | $260.00 | −$69.4K | −20.8%1.02K after | |
| Sep 8, 2021 (view filing) | Sep 8 | Same day | Hickey DavidEVP & President, Life Sciences | SSale | −500 | $260.00 | −$130.0K | −12.2%3.59K after | |
| Sep 8, 2021 (view filing) | Sep 8 | Same day | Rimel Rebecca WDirector | SSale | −500 | $260.00 | −$130.0K | −4.5%10.6K after | |
| Sep 7, 2021 (view filing) | Sep 3 | 4 days | Lim James CExecutive Vice President | SSale | −6.96K | $257.44 | −$1.79M | −26.0%19.8K after | |
| Sep 3, 2021 (view filing) | Sep 3 | Same day | Rimel Rebecca WDirector | SSale | −500 | $257.10 | −$128.6K | −4.3%11.1K after | |
| Sep 3, 2021 (view filing) | Sep 2 | 1 day | Rimel Rebecca WDirector | SSale | −244 | $254.00 | −$62.0K | −2.1%11.6K after | |
| Aug 31, 2021 (view filing) | Aug 30 | 1 day | Rimel Rebecca WDirector | SSale | −207 | $252.00 | −$52.2K | −1.7%11.9K after | |
| Aug 18, 2021 (view filing) | Aug 18 | Same day | Fraser ClaireDirector | SSale | −387 | $251.58 | −$97.4K | −1.9%20.2K after | |
| Aug 18, 2021 (view filing) | Aug 17 | 1 day | Rimel Rebecca WDirector | SSale | −207 | $252.00 | −$52.2K | −1.7%12.1K after | |
| Aug 9, 2021 (view filing) | Aug 6 | 3 days | Spoerel Thomas JVP Controller & Chief Acct Off | SSale | −266 | $242.30 | −$64.5K | −17.2%1.28K after |